Enalapril Attenuates Oxidative Stress in Diabetic Rats
- 1 November 2001
- journal article
- Published by Wolters Kluwer Health in Hypertension
- Vol. 38 (5) , 1130-1136
- https://doi.org/10.1161/hy1101.092845
Abstract
Oxidative stress is involved in both the pathogenesis and complications of diabetes. ACE inhibitors can slow the progression of cardiac and renal impairments related to diabetes. The effect of enalapril treatment on oxidative stress and tissue injury was studied in hearts, kidneys, and livers from streptozotocin-induced diabetic rats. Twenty-four rats were divided into the following groups: streptozotocin (65 mg/kg, single intraperitoneal dose), streptozotocin+enalapril (20 mg enalapril/L drinking water), and control (intraperitoneal saline). Seven months after streptozotocin injection, organs were studied by light microscopy and collagen III immunolabeling. Tissue lesions and collagen labeling were graded by a semiquantitative score (0 to 4). Total glutathione content, glutathione redox status (reduced/oxidized glutathione), antioxidant enzyme activities, protein-associated sulfhydryls, thiobarbituric acid–reactive substances, and fluorescent chromolipids were determined in tissue homogenates. Glycemia was higher in both the streptozotocin and streptozotocin+enalapril groups relative to the control group. In the streptozotocin group, creatinine clearance and body weight were lower, and systolic blood pressure and urinary albumin excretion were higher than in the streptozotocin+enalapril and control groups. Heart, kidney, and liver lesion/labeling scores were significantly higher in the streptozotocin group compared with the streptozotocin+enalapril and control groups. Kidney and liver total glutathione was lower in the streptozotocin group relative to the control group ( P P P P <0.05). Tissue fibrosis scores were inversely correlated with (1) both total glutathione and reduced/oxidized glutathione in heart, kidney, and liver and (2) glutathione reductase activity in the kidney. These results suggest that in streptozotocin-induced diabetic rats, the protective action of enalapril might be mediated, at least in part, by its effect on tissue oxidant/antioxidant status.Keywords
This publication has 27 references indexed in Scilit:
- Higher levels of antioxidant defenses in enalapril-treated versus non–enalapril-treated hemodialysis patientsAmerican Journal of Kidney Diseases, 1999
- Effect of angiotensin convertase inhibitors and AT1 angiotensin receptor antagonists on the development of oxidative stress in the kidney of diabetic ratsClinica Chimica Acta; International Journal of Clinical Chemistry, 1999
- α-lipoic acid decreases oxidative stress even in diabetic patients with poor glycemic control and albuminuriaFree Radical Biology & Medicine, 1999
- The induction of GSH synthesis by nanomolar concentrations of NO in endothelial cells: a role for γ‐glutamylcysteine synthetase and γ‐glutamyl transpeptidaseFEBS Letters, 1999
- Pancreatic β Cell–specific Expression of Thioredoxin, an Antioxidative and Antiapoptotic Protein, Prevents Autoimmune and Streptozotocin-induced DiabetesThe Journal of Experimental Medicine, 1998
- Oxidative damage and fibrogenesisFree Radical Biology & Medicine, 1997
- Angiotensin II-mediated hypertension in the rat increases vascular superoxide production via membrane NADH/NADPH oxidase activation. Contribution to alterations of vasomotor tone.Journal of Clinical Investigation, 1996
- Superoxide dismutase and glutathione peroxidase activities are increased by enalapril and captopril in mouse liverFEBS Letters, 1995
- Role of Oxidative Stress in Development of Complications in DiabetesDiabetes, 1991
- Fatty liver hepatitis (steatohepatitis) and obesity: An autopsy study with analysis of risk factorsHepatology, 1990